Table 4.

End-of-treatment overall response rate

Patients, n (%)	G-FC (n = 21)	G-B (n = 20)
ORR (CR + CRi + PR)	13 (62)	18 (90)
CR	2 (10)	4 (20)
CRi	3 (14)	5 (25)
PR	8 (38)	9 (45)
SD	4 (19)	0
PD	0	0
Not evaluable*	1 (5)	1 (5)
Missing†	3 (14)	1 (5)

PD, progressive disease; PR, partial response; SD, stable disease.

^*Not evaluable. G-FC (n = 1) and G-B (n = 1): end-of-treatment CT not evaluable.

^†Missing. G-FC: response assessed too early (n = 1); early treatment discontinuation due to adverse event (n = 2). G-B: response assessed too early (n = 1).